MeSH Browser

MeSH Heading: Lipodystrophy, Familial Partial
Tree Number(s): C16.320.488.813; C17.800.849.391.700; C18.452.584.563.798; C18.452.584.625.700; C18.452.880.391.700
Unique ID: D052496
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D052496
Scope Note: Inherited conditions characterized by the partial loss of ADIPOSE TISSUE, either confined to the extremities with normal or increased fat deposits on the face, neck and trunk (type 1), or confined to the loss of SUBCUTANEOUS FAT from the limbs and trunk (type 2). Type 3 is associated with mutation in the gene encoding PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA.
Entry Term(s): Dunnigan Syndrome; Familial Partial Lipodystrophy; Familial Partial Lipodystrophy, Kobberling Type; Familial Partial Lipodystrophy, Type 1; Familial Partial Lipodystrophy, Type 2; Familial Partial Lipodystrophy, Type 3; Koberling-Dunnigan Syndrome; Lipodystrophy, Familial Partial, Associated With PPARg Mutations; Lipodystrophy, Familial Partial, Dunnigan Type; Lipodystrophy, Familial Partial, Kobberling Type; Lipodystrophy, Familial Partial, Type 1; Lipodystrophy, Familial Partial, Type 2; Lipodystrophy, Familial Partial, Type 3; Lipodystrophy, Familial, of Limbs and Lower Trunk; Lipodystrophy, Reverse Partial
Previous Indexing: Lipodystrophy (1975-2006)
See Also: PPAR gamma
Public MeSH Note: 2007; see DIABETES MELLITUS, LIPOATROPHIC 2005-2006
History Note: 2007; use DIABETES MELLITUS, LIPOATROPHIC 2005-2006
Date Established: 2007/01/01
Date of Entry: 2006/07/05
Revision Date: 2021/07/01

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

chemically induced (CI)

classification (CL)

complications (CO)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

urine (UR)

veterinary (VE)

virology (VI)

Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
  - Laminopathies [C16.320.488]

Skin and Connective Tissue Diseases [C17]
- Skin Diseases [C17.800]
  - Skin Diseases, Metabolic [C17.800.849]
    - Lipodystrophy [C17.800.849.391]

Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
  - Lipid Metabolism Disorders [C18.452.584]
    - Lipid Metabolism, Inborn Errors [C18.452.584.563]

Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
  - Lipid Metabolism Disorders [C18.452.584]
    - Lipodystrophy [C18.452.584.625]

Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
  - Skin Diseases, Metabolic [C18.452.880]
    - Lipodystrophy [C18.452.880.391]

Lipodystrophy, Familial Partial Preferred

Concept UI: M0462327
Scope Note: Inherited conditions characterized by the partial loss of ADIPOSE TISSUE, either confined to the extremities with normal or increased fat deposits on the face, neck and trunk (type 1), or confined to the loss of SUBCUTANEOUS FAT from the limbs and trunk (type 2). Type 3 is associated with mutation in the gene encoding PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA.
Terms: Lipodystrophy, Familial Partial Preferred Term
Term UI T576972
Date03/15/2004
LexicalTag NON
ThesaurusID NLM (2005); Familial Partial Lipodystrophy
Term UI T646771
Date07/25/2005
LexicalTag NON
ThesaurusID NLM (2007); Koberling-Dunnigan Syndrome
Term UI T576975
Date03/15/2004
LexicalTag EPO
ThesaurusID NLM (2005)

Familial Partial Lipodystrophy, Type 2 Narrower

Familial Partial Lipodystrophy, Type 3 Narrower

Familial Partial Lipodystrophy, Type 1 Narrower

Lipodystrophy, Familial Partial MeSH Descriptor Data 2024